Cloning of human cord blood-mesenchymal stem cells for isolation of enriched cell population of higher proliferation and differentiation potential

Bibliographic Information
Authors: Demerdash Z.; El Baz H.; Ali N.; Mahmoud F.; Mohamed S.; Khalifa R.; Hassan M.; Shawky S.
Journal: Molecular Biology Reports
Publisher: Springer
Publication Date: 11 May 2020
Volume / Issue: Volume 47 / Issue 5
Pages: 3963–3972
ISSN: 3014851
DOI: 10.1007/s11033-020-05489-1
Scopus: View on Scopus
PubMed: 32394306
Document Type: Article
Authors and Affiliations
Demerdash Z., Immunology Department, Theodor Bilharz Research Institute, Warrak El-Hadar, Giza, 12411, Egypt; El Baz H., Immunology Department, Theodor Bilharz Research Institute, Warrak El-Hadar, Giza, 12411, Egypt; Ali N., Immunology Department, Theodor Bilharz Research Institute, Warrak El-Hadar, Giza, 12411, Egypt; Mahmoud F., Immunology Department, Theodor Bilharz Research Institute, Warrak El-Hadar, Giza, 12411, Egypt; Mohamed S., Immunology Department, Theodor Bilharz Research Institute, Warrak El-Hadar, Giza, 12411, Egypt; Khalifa R., Clinical and Chemical Pathology Department, Kasr Al-Ainy, Faculty of Medicine, Cairo University, Cairo, Egypt; Hassan M., Immunology Department, Theodor Bilharz Research Institute, Warrak El-Hadar, Giza, 12411, Egypt; Shawky S., Clinical and Chemical Pathology Department, Kasr Al-Ainy, Faculty of Medicine, Cairo University, Cairo, Egypt
Abstract
Heterogeneity of Mesenchymal stem cells (MSCs) imposes limitations for their in vitro expansion and accounts for the lack of reproducibility in some clinical studies. So, this study was designed to isolate and enrich clones of multipotent and self-renewing MSCs from cord blood (CB). Enriched clones with higher proliferation and differentiation potential provide regenerative cells suitable for various clinical demands. MSCA and MSCB original (progenitor) cells were isolated from CB samples, and single cells were cloned by limiting dilution method, in mouse embryonic fibroblast conditioned media. Original MSCs and their single-cell derived clones were characterized by identifying their proliferation rate, immunophenotyping of surface antigens, expression of pluripotency and proliferation genes (Oct4, Sox2, Nanog, KLF4, c-Myc, and PDGFRA), and differentiation potential into multiple lineages (osteogenic, adipogenic, and chondrogenic). Some single-cell clones of MSCA showed a higher proliferation rate and greater differentiation potential than their original cells. However, original MSCB cells were of greater proliferation and differentiation potential than their derived single-cell clones, except for one clone which had comparable results. Cloning of MSCs was attainable when cultured in mouse embryonic fibroblast conditioned media. Single clones with higher proliferation and differentiation potential than their original progenitor cells were obtained by cloning of poorly functioning MSCs progenitor cells, enabling the selection of more therapeutically efficacious MSCs with better performance in clinical applications. Moreover, this study draws attention to the importance of CD105 as a possible MSCs biomarker associated with the multilineage commitment of MSCs. © 2020, Springer Nature B.V.
Keywords
Cloning; Cord blood-mesenchymal stem cells; Differentiation potential; Limiting dilution method; Pluripotency genes; Adipogenesis; Cell Differentiation; Cell Proliferation; Cells, Cultured; Chondrogenesis; Cloning, Molecular; Fetal Blood; Humans; Immunophenotyping; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Reproducibility of Results; Umbilical Cord; endoglin; kruppel like factor 4; membrane antigen; Myc protein; octamer transcription factor 4; platelet derived growth factor alpha receptor; transcription factor NANOG; transcription factor Sox2; Article; bone development; cell cloning; cell culture; cell function; cell isolation; cell population; cell regeneration; cell self-renewal; gene expression; human; human cell; mesenchymal stem cell; umbilical cord blood; cytology; fetus blood; metabolism; molecular cloning; physiology; procedures; reproducibility
Citation Information
Scopus Citations: 7
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
